M L Disis|M A Cheever - JoVE Visualize

Showing results (51-60 of 109) with videos related to

Pageof 11

Sort By:

The Journal of Experimental Medicine|May 1, 1985

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cellsP D Greenberg, D E Kern, M A Cheever

Journal of Virology|November 1, 1996

Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumorsW Chen, H Qin, B Chesebro, et al.

Breast Cancer Research and Treatment|November 10, 2000

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancerM L Disis, K L Knutson, K Schiffman, et al.

Critical Reviews in Immunology|October 20, 2001

Clinical translation of peptide-based vaccine trials: the HER-2/neu modelM L Disis, K L Knutson, D G McNeel, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1991

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenesD J Peace, W Chen, H Nelson, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998

CTLs specific for bcr-abl joining region segment peptides fail to lyse leukemia cells expressing p210 bcr-abl proteinW Chen, H Qin, V A Reese, et al.

The Journal of Experimental Medicine|April 1, 1982

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2M A Cheever, P D Greenberg, A Fefer, et al.

Transplantation|April 1, 1977

Reduction of fatal graft-versus-host disease by 3H-thymidine suicide of donor cells cultured with host cellsM A Cheever, A B Einstein, R A Kempf, et al.

Progress in Clinical and Biological Research|January 1, 1987

Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivoM A Cheever, J P Klarnet, D J Peace, et al.

Cancer Research|October 1, 1990

Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cellsD E Kern, J P Klarnet, M A Cheever, et al.

Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:

Pageof 11

The Journal of Experimental Medicine|May 1, 1985

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cellsP D Greenberg, D E Kern, M A Cheever

Journal of Virology|November 1, 1996

Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumorsW Chen, H Qin, B Chesebro, et al.

Breast Cancer Research and Treatment|November 10, 2000

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancerM L Disis, K L Knutson, K Schiffman, et al.

Critical Reviews in Immunology|October 20, 2001

Clinical translation of peptide-based vaccine trials: the HER-2/neu modelM L Disis, K L Knutson, D G McNeel, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1991

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenesD J Peace, W Chen, H Nelson, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998

CTLs specific for bcr-abl joining region segment peptides fail to lyse leukemia cells expressing p210 bcr-abl proteinW Chen, H Qin, V A Reese, et al.

The Journal of Experimental Medicine|April 1, 1982

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2M A Cheever, P D Greenberg, A Fefer, et al.

Transplantation|April 1, 1977

Reduction of fatal graft-versus-host disease by 3H-thymidine suicide of donor cells cultured with host cellsM A Cheever, A B Einstein, R A Kempf, et al.

Progress in Clinical and Biological Research|January 1, 1987

Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivoM A Cheever, J P Klarnet, D J Peace, et al.

Cancer Research|October 1, 1990

Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cellsD E Kern, J P Klarnet, M A Cheever, et al.

Pageof 11